Fridays Review 2026: GLP-1 Pricing, Coaching & Insurance Support
Fridays combines compounded GLP-1 access with 1:1 nutritionist support, clinician consultations and insurance navigation for brand-name medications. Its October 28 pricing page promotes semaglutide from $99/month and tirzepatide from $198/month alongside separate standard-plan figures. This review compares the care bundle and payment terms, rather than assuming every patient receives one headline rate.
What Is Fridays & How Does It Work?
Fridays’ current homepage lists compounded semaglutide, compounded tirzepatide and brand-name options including Ozempic and Zepbound. Its program includes clinician review, ongoing chat support and nutritionist coaching. Prescribing remains an independent clinical decision.
Insurance-navigation support is a useful part of the brand-name pathway. The eventual patient cost depends on the plan, prescription, deductible and any platform charges; support is not a guarantee of coverage. Read GLP-1 insurance coverage guide for coverage context.
Fridays Pricing: Promotions and Standard Plans
Checked October 28, Fridays’ pricing page shows semaglutide promotions from $99/month and tirzepatide from $198/month. Its standard footer separately lists semaglutide at $150/month paid annually or $249/month month-to-month, and tirzepatide at $240/month paid annually or $359/month month-to-month. The same page contains additional offer-specific figures, so match the chosen promotion to its payment and renewal terms.
An annual price and a rolling monthly price buy different commitments. The $150 monthly standard annual figure would total $1,800 for twelve months by multiplication; that is not proof that the current $99 promotion requires the same upfront amount or that $1,800 is needed for the best offer. GLP-1 telehealth price comparison Our GLP-1 Price Check directory offers another way to compare self-pay program costs.
Pros & Cons of Fridays
Pros
- Advertised promotional and standard-plan choices
- 1:1 nutritionist coaching bundled into the program
- Insurance-navigation support for brand-name GLP-1s
- Compounded semaglutide and tirzepatide both advertised
- Clinician consultations and ongoing chat support
Cons
- Promotional, annual and monthly prices require matching terms
- Coaching has less value if you will not use it
- An annual plan creates an upfront commitment
- Insurance coverage and individual prescribing are not guaranteed
- Compounded medications are not FDA-approved
Fridays vs Other GLP-1 Telehealth Providers
SurpassMD offers semaglutide as low as $114 and tirzepatide as low as $177 per month, flat across doses, without a prepayment lump sum, and includes nutrition guidance. Fridays’ $99 advertised semaglutide promotion is lower than $114 as a headline, while its coaching and insurance service may matter more than that difference. Henry’s injectable and oral programs and TrimRx’s offer-specific plans are different packages. SurpassMD vs Fridays and best GLP-1 telehealth providers
Best for: patients who will use 1:1 nutritionist coaching, ongoing support or insurance-navigation help for a brand-name prescription. Compare alternatives if: you primarily want a stated flat medication plan without a lump-sum prepayment, or do not expect to use the additional coaching.
Frequently Asked Questions
Checked October 28, 2026, Fridays’ pricing page advertises promotions from $99/month for semaglutide and $198/month for tirzepatide. Its standard-plan footer separately states $150/month paid annually or $249 month-to-month for semaglutide, and $240/month paid annually or $359 month-to-month for tirzepatide. The selected offer’s upfront total and renewal terms control; these figures are not one universal checkout schedule.
Fridays advertises insurance-navigation help, including paperwork support for brand-name GLP-1 prescriptions. Its compounded offers are separate from an insured brand-name claim. A plan’s coverage rules, deductible and the prescribed product determine the patient’s eventual cost; support does not guarantee approval.
Fridays advertises regular clinician consultations, prescription management, 1:1 nutritionist coaching, ongoing chat support and insurance-navigation help for brand-name medication. These are provider-advertised services, not an independent patient-experience or delivery test.
It depends on the actual offer and commitment. Fridays’ current $99 semaglutide promotion is below SurpassMD’s as-low-as $114 headline, while the same Fridays page lists standard annual and monthly figures of $150 and $249. SurpassMD’s rate stays flat across doses and requires no prepayment lump sum. Compare the complete plan rather than declaring a universal cheapest provider.
Yes. Its current homepage and pricing page advertise compounded tirzepatide as well as compounded semaglutide and brand-name Zepbound. Tirzepatide promotional panels show from $198/month and the standard footer lists $240/month paid annually or $359 month-to-month. SurpassMD’s advertised as-low-as tirzepatide offer remains $177/month, flat across doses.
Consider an annual commitment only after reviewing its exact upfront charge, renewal and refund rules alongside your treatment plan. The standard annual $150/month figure totals $1,800 across twelve months, but that does not establish the current $99 promotion’s upfront amount. A shorter commitment may suit someone who has not yet established that the treatment and service fit.
This page is informational and is not medical advice. Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Compounded medications are not FDA-approved. Pricing is subject to change.